Results 111 to 120 of about 122,840 (288)
Marketing a healthier choice: exploring young people’s perception of e-cigarettes [PDF]
, 2017 Background: As a consequence of insufficient evidence on the safety and efficacy of e cigarettes, there has been much controversy surrounding its use in the tobacco control field.
Allison, S, Brown, A
core
E-Cigarette Versus Nicotine Inhaler: Comparing the Perceptions and Experiences of Inhaled Nicotine Devices [PDF]
, 2014 Michael Steinberg +6 more
openalex +1 more source
Chronic Diseases and Translational Medicine, EarlyView.ABSTRACT Background Chronic diseases represent a growing public health challenge globally, particularly in developing regions like Sub‐Saharan Africa. Somaliland faces a dual burden of communicable and non‐communicable diseases amidst post‐conflict recovery, yet data on non‐communicable disease (NCD) prevalence and determinants remain scarce.
Abdirahman Omer Ali +5 more
wiley +1 more source
ChemistryEurope, EarlyView.C3‐Symmetric aluminum chelate complexes endowed with tripodal tris‐silanolate ligands are shown to be excellent catalysts for the selective carbonyl ene‐type cyclization of citronellal to isopulegol as the key intermediate of the current industrial syntheses of menthol.
J. Nepomuk Korber, Alois Fürstner
wiley +1 more source
An exploration of flavours in studies of e‐cigarettes for smoking cessation: secondary analyses of a systematic review with meta‐analyses [PDF]
, 2022 Nicola Lindson +8 more
openalex +1 more source
ChemFoodChem, EarlyView.Abstract Vegetables are rich in bioactive compounds, including fibers and minerals, providing a conspicuous contribution to achieving health benefits. In this study, black kale (Brassica oleracea var. acephala, BK) was fermented using Saccharomyces cerevisiae LI180‐7 strain at pilot scale, producing a safe and consumable product featured by improved ...
Mirco Vacca +15 more
wiley +1 more source
Clinical Pharmacology in Drug Development, EarlyView.Abstract This 2‐part, randomized, placebo‐controlled, double‐blind, Phase 1 study analyzed the pharmacokinetics, safety, and biomarker profile of fezolinetant in healthy Japanese individuals. Part 1: male participants received single doses of placebo or fezolinetant 15 or 60 mg.
Akira Koibuchi +8 more
wiley +1 more source
Conventional Cigarette and E-Cigarette Smoking among School Personnel in Shanghai, China: Prevalence and Determinants [PDF]
, 2019 Jingfen Zhu +6 more
openalex +1 more source
E-Cigarette Use and Subclinical Cardiac Effects [PDF]
, 2020 Florian Rader +14 more
openalex +1 more source
Vaping and E-Cigarettes Within the Evolving Tobacco Quitline Landscape [PDF]
, 2021 Katrina A. Vickerman +5 more
openalex +1 more source